Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab Effects on Lipids and Arterial Stiffness in RA
NCT00535782Phase 3Completed
- Sponsor
- Roche
- Start
- Oct 2007
- Primary completion
- Sep 2008
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 4
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Oct 2007; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00535782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535782.